One emerging NYSE company has created NV-387, which is designed to employ advanced "host-mimetic" technology, and could be a viable clinical candidate for drug development to treat COVID, Long COVID, as well as potentially MERS, SARS, and seasonal coronavirus infections.
| |
| |
| | Below is an important message from one of our valued partners along with today's top headlines. | | | |
| |
|  NYSE Biotech Company's Drug Could Be as Revolutionary as Penicillin! - Ad
One emerging NYSE company has created NV-387, which is designed to employ advanced "host-mimetic" technology, and could be a viable clinical candidate for drug development to treat COVID, Long COVID, as well as potentially MERS, SARS, and seasonal coronavirus infections. Learn more about NV-387 |
This message is sent on behalf of Interactive Offers, LLC, a third-party advertiser. Musth Corp receives a fixed fee for each subscriber that clicks on a link in this email. See our disclaimer for further details on compensation, affiliation and ethics. | | | | |  IPO Previews For The Week
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week. Continue reading ➔ | | | | | | |  (Free Report) Today's Top 5 Stocks Priced Below $10 - Ad
Investing in stocks under $10 could increase the returns on your portfolio, especially if you pick the right stocks. Within this report you will find 5 top stocks that offer the best bang for the buck. Add them to your watchlist before they take off!
| | | | | | By clicking the link above you will automatically opt-in to receive emails from ActivaTrade and agree to Privacy Policy | | | | | |  Bloodbath Coming on August 1st? - Ad
Legendary trader Tom Gentile has just issued this critical warning for August 1st. Something big is happening...And if you don't prepare now, you could end up losing a big chunk of your savings. No wonder billionaires like Warren Buffett and Bill Ackman have already started to prepare. Get the details before it's too late. | | | | | | |
| Information, charts or examples contained in this email are for illustration and educational purposes only and not for individualized investment management. This message contains commercial elements, such as advertising as well as partner offers for which we may receive affiliate compensation. We only send these offers to those who have opted in to our newsletter. If you wish to no longer receive these offers click on the unsubscribe link at the bottom of this email. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained in this email or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.
339-20 De Boers Dr., Toronto, ON M3J 0H1, 917.672.7040
© 2024 Musth | PriceActionEA | All rights reserved.
Unsubscribe | | | | |
Post a Comment
Post a Comment